Back to School: How biopharma can reboot drug development. Access exclusive analysis here

MorphoSys partnerships

MorphoSys partnerships

Partner Announced Duration (expiration) Description
Astellas (Tokyo:4503) 2007 Up to 5 yrs (3/2012) Licenses MOR's HuCAL GOLD antibody library for internal discovery programs
Bayer Schering (A) 1999 (Bayer

Read the full 304 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE